Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril

American Journal of Cardiology

Volumn 81, Issue 2, 1998, Pages 170-174

  González Juanatey, José Ramón ^a   García Acuña, José Maria ^a   Pose, Antonio ^a   Varela, Alfonso ^a   Calvo, Carlos ^a   Cabezas Cerrato, José ^a   De La Peña, Miguel Gil ^a  

^a HOSPITAL GENERAL DE GALICIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE ARRHYTHMIA; HUMAN; LONG TERM CARE; M MODE ECHOCARDIOGRAPHY; MALE; PRIORITY JOURNAL; PROGNOSIS; QT INTERVAL;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZOTHIADIAZINES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIURETICS; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SODIUM CHLORIDE SYMPORTER INHIBITORS; STROKE VOLUME;

EID: 0032518836     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00869-2     Document Type: Article

References (29)

1. 1. Schwartz P, Wolf S. QT interval prolongation as a predictor of sudden death in patients with myocardial infarction. Circulation 1978;57:1074-1077.
2. 2. Hii JTY, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Precordial QT interval dispersion as a marker of torsades de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation 1992;86:1376-1382.
3. 3. Buja G, Miorelli M, Turrini P, Melacini P, Nava A. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993;72:973-976.
4. 4. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343:327-329.
5. 5. Topol EJ, Lerman B. Hypomagnesemic torsades de pointes. Am J Cardiol 1983;52:1367-1368.
6. 6. Bauman JL, Bauernfeind RA, Hoff JV, Strasberg B, Swiryn S, Rosen KM. Torsades de pointes due to quinidine: observations in 31 patients. Am Heart J 1984;107:425-430.
7. 7. Tzivoni D, Keren A, Stern S, Gottlieb S. Disopyramide-induced torsades de pointes. Arch Intern Med 1981;141:946-947.
8. 8. Ichkhan K, Molnar J, Somberg J. Relation of left ventricular mass and QT dispersion in patients with systematic hypertension. Am J Cardiol 1997;79:508-511.
9. 9. Mayet J, Shahi M, McGrath K, Poulter NR, Sever PS, Foale RA, Thom SAM. Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension 1996;28:791-796.
10. 10. González-Juanatey JR, Pose A, Garcia-Acuña JM, Castelo V, Amaro A, Calvo C, Gil M. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment. Eur Heart J 1995;16:1981-1987.
11. 11. González-Juanatey JR, Pose A, Varela A, García JM, Fernández JA, Cabezas J. Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril. Am J Cardiol 1997;79:373-376.
12. 12. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in men: anatomic validation of the method. Circulation 1977;55:613-618.
13. 13. Bazett HC. An analysis of the time relations of electrocardiograms. Heart 1920;7:353-370.
14. 14. Yurenev AP, Dyakonova HG, Novikov ID, Vitols A, Pahl L, Hayneman G. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Am J Hypertens 1992;5:5182-5189.
15. 15. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1995;13:1091-1095.
16. 16. Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Frohlich ED. Hypertension and sudden death: increased ventricular ectopy activity in left ventricular hypertrophy. Am J Med 1984;77:18-22.
17. 17. McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987;317:787-792.
18. 18. Pose-Reino A, González-Juanatey JR, Pastor C, Méndez I, Estevez JC, Cabezas-Cerrato J. Estructura miocárdica y estudio de las arrítmias durante el registre electrocardiográfico ambulatorio en la hipertensión arterial ligera. Med Clin (Barc) 1996;106:7-10.
19. 19. Higham PD, Furniss SS, Campbell RWF. QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J 1995;73:32-36.
20. 20. Tieleman RG, Crijns HJGM, Wiesfeld ACP, Posma J, Hamer HPM, Lie KI. Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias. Br Heart J 1995;73:37-40.
21. 21. Bogun F, Chan KK, Harvey M, Goyal R, Castellani M, Niebauer M, Daoud E, Man KC, Strickenberger A, Morady F. QT dispersion in nonsustained ventricular tachycardia and coronary heart disease. Am J Cardiol 1996;77:256-259.
22. 22. Zabel M, Portnoy S, Franz M. ECG indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 1995;25: 746-752.
23. 23. Barr CS, Naas AA, Fenwick M, Struthers AD. Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease. Am J Cardiol 1997;79:328-333.
24. 24. Pye M, Quinn AC, Cobbe SM. QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias. Br Heart J 1994;71:511-514.
25. 25. Unger T, Torsen M, Lamberty V. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension 1992;20:478-482.
26. 26. Brush JE, Faxon DP, Salmon S, Jacobs AK, Ryan TJ. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol 1992;19:809-815.
27. 27. Iriarte M, Caso R, Murga N, Boveda J, Saenz R, Lopez de Argumedo M. Enalapril-induced regression of hypertensive left ventricular hypertrophy, regional ischaemia, and microvascular angina. Am J Cardiol 1995;75:850-852.
28. 28. Moreno FL, Villanueva T, Karagounis LA, Anderson JL, for TEAM-2. Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. Circulation 1994;90:94-100.
29. 29. Bruckschlegel G, Holmer SR, Jandeleit K, Grimm D, Muders F, Kromer EP, Riegger GAJ, Schunkert H. Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension 1995;25:250-259.